NEW YORK, NY / ACCESS Newswire / September 26, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Novo Nordisk A/S (NYSE:NVO) class action securities lawsuit
A Class Action lawsuit was filed on behalf of Novo Nordisk A/S investors who lost money as a result of alleged securities fraud between May 7, 2025 and July 28, 2025.
Levi & Korsinsky has released a Podcast describing the nature of the action. The podcast for this class action lawsuit can be found here:
According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Novo’s growth potential; notably, that its asserted potential to capitalize on the compounded market greatly understated the potential impact of the personalization exception to the compounded GLP-1 exclusion and overstated the likelihood such patients would switch to Novo’s branded alternatives, and further greatly overstated the potential GLP-1 market or otherwise Novo’s capability to penetrate said markets to achieve continued growth.
On July 29, 2025, Novo announced it was lowering its sales and profit outlook ahead of reporting its results for the second quarter of fiscal year 2025. The Company attributed the guide down on "lowered growth expectations for the second half of 2025" for both Wegovy and Ozempic due to "the persistent use of compounded GLP-1s, slower-than-expected market expansion and competition."
Following this news, the price of Novo’s common stock declined dramatically. From a closing market price of $69.00 per share on July 28, 2025, Novo’s stock price fell to $53.94 per share on July 29, 2025, a decline of about 21.83% in the span of just a single day.
If you have any questions about this class action lawsuit or any other sudden or unexpected stock loss, feel free to contact Levi & Korsinsky at (212)-363-7500.
You can also find recent podcasts regarding other class actions lawsuits and topics which are of interest to shareholders that have lost money in the stock market, here:
https://suewallst.podbean.com/
LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP
View the original press release on ACCESS Newswire
COMTEX_469070058/2457/2025-09-26T10:02:58